297 Results for "

IGF

" in MedChemExpress (MCE) Product Catalog:
Products (297)

297 Results for "IGF" in MCE Product Catalog:

51
51 Publications Verification
Referencia número: HY-10191
No. CAS: 867160-71-2
Pureza:  99.87%
Synonyms: OSI-906
Target:  

IGF-1R Insulin Receptor

Áreas de investigación:  

Endocrinology Cancer

Linsitinib (OSI-906) is a potent, selective and orally bioavailable dual inhibitor of the IGF-1 receptor and insulin receptor (IR) with IC50s of 35 and 75 nM, respectively .
loading...
    loading...
43
43 Cited Publications
Referencia número: HY-15656
No. CAS: 1032900-25-6
Pureza:  99.98%
Synonyms: LDK378
Ceritinib (LDK378) is a selective, orally bioavailable, and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM. Ceritinib also inhibits IGF-1R, InsR, and STK22D with IC50 values of 8, 7, and 23 nM, respectively. Ceritinib shows great antitumor potency .
loading...
    loading...
43
43 Cited Publications
Referencia número: HY-15656A
No. CAS: 1380575-43-8
Pureza:  99.90%
Synonyms: LDK378 dihydrochloride
Ceritinib (LDK378) dihydrochloride is a selective, orally bioavailable and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM. Ceritinib dihydrochloride also inhibits IGF-1R, InsR, and STK22D with IC50 values of 8, 7, and 23 nM, respectively. Ceritinib dihydrochloride shows great antitumor potency .
loading...
    loading...
31
31 Cited Publications
Referencia número: HY-15494
No. CAS: 477-47-4
Pureza:  99.85%
Synonyms: AXL1717; Picropodophyllotoxin; PPP
Picropodophyllin (AXL1717) is a selective insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 of 1 nM.
loading...
    loading...
27
27 Cited Publications
Referencia número: HY-P7018
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuIGF-1; IGF-IA; Somatamedin C; MGF; IGF-I
Species:  
Source:  
loading...
    loading...
14
14 Cited Publications
Referencia número: HY-10200
No. CAS: 1001350-96-4
Pureza:  99.42%
Target:  

IGF-1R Insulin Receptor

Áreas de investigación:  

Endocrinology Cancer

BMS-754807 is a potent and reversible IGF-1R/IR inhibitor (IC50=1.8 and 1.7 nM, respectively; Ki=<2 nM for both). BMS-754807 also shows potent activities against Met, RON, TrkA, TrkB, AurA, and AurB with IC50 values of 6, 44, 7, 4, 9, and 25 nM, respectively .
loading...
    loading...
13
13 Cited Publications
Referencia número: HY-50866
No. CAS: 475489-16-8
Synonyms: AEW541
Áreas de investigación:  

Endocrinology Cancer

NVP-AEW541 (AEW541 ) is an orally active inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with an IC50 value of 0.15 μM. NVP-AEW541 also inhibits InsR, IC50 with a value of 0.14 μM. NVP-AEW541 has antitumor activity .
loading...
    loading...
12
12 Cited Publications
Referencia número: HY-P7070
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rMuIGF-1; IGF-IA; Somatamedin C; MGF; IGF-I
Species:  
Source:  
loading...
    loading...
11
11 Cited Publications
Referencia número: HY-13203
No. CAS: 761437-28-9
Pureza:  99.77%
Synonyms: TAE226
Áreas de investigación:  

Endocrinology Cancer

NVP-TAE 226 (TAE226) is a potent and ATP-competitive dual FAK and IGF-1R inhibitor with IC50s of 5.5 nM and 140 nM, respectively. NVP-TAE 226 (TAE226) also effectively inhibits Pyk2 and insulin receptor (InsR) with IC50s of 3.5 nM and 44 nM, respectively .
loading...
    loading...
10
10 Cited Publications
Referencia número: HY-W112938
No. CAS: 92739-63-4
TMPyP tetrachloride is a quadruplex-specific ligand. TMPyP tetrachloride inhibits the interaction between G-quadruplexes and IGF-1. TMPyP tetrachloride is a telomerase inhibitor and inhibits cancer cells proliferation. TMPyP tetrachloride is also a stabilizer of nucleic acid secondary structure and an acetylcholinesterase inhibitor. Besides, TMPyP tetrachloride has antiviral activity against SARS-CoV-2 .
loading...
    loading...
10
10 Cited Publications
Referencia número: HY-108477
No. CAS: 36951-72-1
Pureza:  ≥98.0%
Synonyms: TMP 1363
Áreas de investigación:  

Cancer

TMPyP4 tosylate (TMP 1363) is a quadruplex-specific ligand. TMPyP4 tosylate inhibits the interaction between G-quadruplexes and IGF-1. TMPyP4 tosylate is a telomerase inhibitor and inhibits cancer cells proliferation. TMPyP4 tosylate is also a stabilizer of nucleic acid secondary structure and an acetylcholinesterase inhibitor. Besides, TMPyP4 tosylate has antiviral activity against SARS-CoV-2 .
loading...
    loading...
8
8 Cited Publications
Referencia número: HY-116624
No. CAS: 163655-37-6
Pureza:  99.76%
Target:  

VEGFR Apoptosis

Áreas de investigación:  

Cancer

MAZ51 is a selective inhibitor of VEGFR-3 (Flt-4) tyrosine kinase. MAZ51 inhibits VEGF-C-induced activation of VEGFR-3 without blocking VEGF-C-mediated stimulation of VEGFR2. MAZ51 had no effect on ligand-induced autophosphorylation of EGFR, IGF-1R and PDGFRβ. MAZ51 blocks proliferation and induces apoptosis in a wide variety of tumor cells. Antitumor activity .
loading...
    loading...
8
8 Cited Publications
Referencia número: HY-13020
No. CAS: 1116235-97-2
Pureza:  99.58%
GSK1838705A is a potent and reversible IGF-IR and the insulin receptor inhibitor with IC50s of 2.0 and 1.6 nM, respectively. It also inhibits ALK with an IC50 of 0.5 nM.
loading...
    loading...
7
7 Cited Publications
Referencia número: HY-10524
No. CAS: 1089283-49-7
Pureza:  99.03%
Áreas de investigación:  

Endocrinology Cancer

GSK1904529A is a potent, selective, orally active, and ATP-competitive inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR), with IC50s of 27 and 25 nM, respectively. GSK1904529A shows poor activity (IC50>1 μM) in 45 other serine/threonine and tyrosine kinases. GSK1904529A exhibits anti-tumor activity .
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-P70788
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Insulin-Like Growth Factor I; IGF-I; Mechano Growth Factor; MGF; Somatomedin-C; IGF1; IBP1
Species:  
Source:  
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-153274
No. CAS: 2408590-36-1
Pureza:  98.18%
Target:  

Apoptosis

Áreas de investigación:  

Cancer

CWI1-2 is an IGF2BP2 inhibitor that binds IGF2BP2 and inhibits its interaction with m6A-modified target transcripts, induces apoptosis and differentiation, and shows promising anti-leukemic effects .
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-153274A
No. CAS: 2408590-37-2
Pureza:  98.27%
Target:  

Apoptosis

Áreas de investigación:  

Cancer

CWI1-2 hydrochloride is an IGF2BP2 inhibitor that binds IGF2BP2 and inhibits its interaction with m6A-modified target transcripts, induces apoptosis and differentiation, and shows promising anti-leukemic effects .
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-10253
No. CAS: 65678-07-1
Pureza:  98.68%
Synonyms: Tyrphostin AG 1024
Áreas de investigación:  

Endocrinology Cancer

AG1024 (Tyrphostin AG 1024) is a reversible, competitive and selective IGF-1R inhibitor with an IC50 of 7 μM. AG1024 inhibits phosphorylation of IR (IC50=57 μM). AG1024 induces apoptosis and has anti-cancer activity .
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-13326
No. CAS: 1097917-15-1
Pureza:  99.88%
ASP3026 is a selective and orally active inhibitor of anaplastic lymphoma kinase (ALK). ASP3026 is a selective and oral active anaplastic lymphoma kinase (ALK) inhibitor with a IC50 value of 3.5 nM. ASP3026 can inhibit the phosphorylation of IGF-1R, STAT3, AKT and JNK proteins, and induce the cleavage of caspase 3 and PARP. It also inhibited ROS and ACK. ASP3026 can be used in anti-tumor research .
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-16381
No. CAS: 396091-73-9
Synonyms: SOM230
Target:  

Somatostatin Receptor

Áreas de investigación:  

Endocrinology Cancer

Pasireotide (SOM230), a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). Pasireotide can suppress GH, IGF-I and ACTH secretion, indicating potential efficacy in acromegaly and Cushing's disease. Pasireotide also exhibits antisecretory, antiproliferative, and proapoptotic activity .
loading...
    loading...